BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6881214)

  • 21. Molecular diagnosis of Duchenne muscular dystrophy by use of a conformational polymorphism in the absence of DNA from an affected boy.
    Tuffery S; Moine P; Sarda P; Lefort G; Boulot P; Demaille J; Claustres M
    Genet Couns; 1994; 5(2):183-5. PubMed ID: 7917130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progressive muscular dystrophy of the Duchenne type. Epidemiology and strategy for prevention].
    Doriguzzi C; Bertolotto A; Mongini T; Monnier C; Palmucci L; Verzè L; Schiffer D
    Minerva Med; 1980 Sep; 71(33):2337-44. PubMed ID: 7001272
    [No Abstract]   [Full Text] [Related]  

  • 23. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection, genetic counseling and phenotype prevention of Duchenne muscular dystrophy].
    Bachmann H; Lössner J; Kühn HJ; Ruchholtz U; Göhler I
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):537-44. PubMed ID: 6514865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DNA markers, genetic counseling and prenatal diagnosis of hereditary disease. A study of 3 families with Duchenne's muscular dystrophy].
    Schwartz M; Nørby S; Brandt NJ
    Ugeskr Laeger; 1985 Jun; 147(26):2071-5. PubMed ID: 3863357
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutants in Duchenne muscular dystrophy. Implications for prevention.
    Roses AD
    Arch Neurol; 1988 Jan; 45(1):84-5. PubMed ID: 3337680
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family.
    Wilton SD; Chandler DC; Kakulas BA; Laing NG
    Hum Mutat; 1994; 3(2):133-40. PubMed ID: 8199594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The current status of studies on the prevention of Duchenne dystrophy].
    Hausmanowa-Petrusewicz I
    Pol Tyg Lek; 1987 Oct 5-12; 42(40-41):1281-3. PubMed ID: 3438204
    [No Abstract]   [Full Text] [Related]  

  • 29. [The importance of biomicroscopic examination of the lens in the detection of heterozygotes for certain hereditary diseases, in particular, myotonic dystrophy].
    Pescia G; Emery AE
    J Genet Hum; 1976 Sep; 24(3):227-34. PubMed ID: 1003175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience in genetic counseling for Duchenne's muscular dystrophy in Reggio Emilia].
    Guidetti D; Marcello N; Motti L; Mammana S; Zucco R; Tagliavini G; Lucci B
    Minerva Pediatr; 1986 Aug; 38(15-16):621-4. PubMed ID: 3796510
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carrier detection of Duchenne/Becker muscular dystrophy by analysis of STRs loci linked to the gene of dystrophin in Venezuelan families].
    Delgado-Luengo WN; Borjas-Fuentes L; Zabala-Fernández W; Fernández-Salgado E; Solís-Añez E; Chávez C; Martínez-Basalo C; González-Ferrer S; Rojas-Atencio A; Morales-Machin A; Peña J; Pineda-Bernal L; González R; Miranda LE; Delgado-Luengo J; Hernández ML; Chacín JA; Quintero M
    Invest Clin; 2002 Dec; 43(4):239-54. PubMed ID: 12520997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Duchenne muscular dystrophy. Review of 37 cases].
    Pascual Pascual SI; López Terradas JM; Pascual Castroviejo I
    An Esp Pediatr; 1982 Oct; 17(4):294-301. PubMed ID: 7158879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.
    Fitzgerald KM; Cibis GW; Gettel AH; Rinaldi R; Harris DJ; White RA
    J Med Genet; 1999 Apr; 36(4):316-22. PubMed ID: 10227401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscular dystrophy: can it be prevented?
    Gardner-Medwin D
    Nurs Times; 1978 Aug; 74(35):1441-3. PubMed ID: 249971
    [No Abstract]   [Full Text] [Related]  

  • 35. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of Bayes theorum in genetic counseling in cases of Duchenne muscular dystrophy].
    Dodinval P
    J Genet Hum; 1979 Jun; 27(2):131-43. PubMed ID: 541678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diagnosis and counseling in a family presenting compound heterozygosity for autosomal recessive limb-girdle muscular dystrophy.
    Dos Santos MR; Vieira EM; Reis Lima M
    Genet Couns; 2001; 12(3):223-9. PubMed ID: 11693784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Erythrocyte membrane in Duchenne muscular dystrophy. I. Sensitivity to lysolecithin in dystrophic patients and their families].
    Grilli G; Bravi S; Angeleri F; Colombi A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2399-402. PubMed ID: 7470282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of genetic counselling in Duchenne muscular dystrophy.
    Emery AE; Watt MS; Clack ER
    Clin Genet; 1972; 3(2):147-50. PubMed ID: 5054316
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular analysis of the Duchenne muscular dystrophy gene in Spanish individuals: deletion detection and familial diagnosis.
    Patiño A; Narbona J; García-Delgado M
    Am J Med Genet; 1995 Nov; 59(2):182-7. PubMed ID: 8588583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.